Loading stock data…
XTNT
$0.55+0.03 (+5.00%)
Market ClosedLast close May 1
Xtant Medical Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Xtant Medical Holdings, Inc. in the Healthcare sector is trading at $0.55. The stock is currently 42% below its 52-week high of $0.95, remaining 14.1% below its 200-day moving average. Technical signals show neutral RSI of 67 and bullish MACD crossover, explaining why XTNT maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 67) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.55
Potential Upside
17.5%
Whystock Fair Value$0.65
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$71.38M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.99
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.16
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.76%
Volume
Today's trading volume
208,059
Recent News
3 Promising Penny Stocks With Market Caps Under $200M
Over the last 7 days, the market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points, especially when backed by strong balance sheets and solid fundamentals. This article explores several penny stocks that stand out as hidden gems, potentially offering both stability and upside in today's market landscape.
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Xtant Medical Holdings Inc (XTNT) reports a significant turnaround with increased revenue and profitability, driven by innovative product launches and strategic focus on high-margin biologics.
Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary
Moby summary of Xtant Medical Holdings, Inc.'s Q4 2025 earnings call
Xtant Medical Q4 Earnings Call Highlights
Xtant Medical (NYSEAMERICAN:XTNT) reported fourth-quarter and full-year 2025 results highlighting modest quarterly revenue growth, improved profitability, and a sharper strategic focus following the sale of non-core assets to Companion Spine. Fourth-quarter results show revenue growth and continued
3 Promising Penny Stocks With Over $90M Market Cap
As the U.S. stock market experiences fluctuations with investors closely monitoring the Federal Reserve's impending decision on interest rates, many are seeking opportunities in less conventional areas of investment. Penny stocks, a term that might seem outdated but remains significant, often represent smaller or newer companies with potential for growth at accessible price points. These stocks can offer intriguing prospects when they possess strong financial health and solid fundamentals,...